Reconsidering the Usefulness of Adding Naloxone to Buprenorphine

Saved in:
Bibliographic Details
Published in:Frontiers in psychiatry 2020-09, Vol.11, p.549272-549272
Main Authors: Blazes, Christopher K., Morrow, Jonathan D.
Format: Article
Language:English
Subjects:
addiction
agonist therapy
diversion
opioids
overdose
Psychiatry
substance use disorders
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-4128c081934a8b91e5099f63b7a02bb0531236c20847046e4b62de115ee176c23
cites cdi_FETCH-LOGICAL-c442t-4128c081934a8b91e5099f63b7a02bb0531236c20847046e4b62de115ee176c23
container_end_page 549272
container_issue
container_start_page 549272
container_title Frontiers in psychiatry
container_volume 11
creator Blazes, Christopher K.
Morrow, Jonathan D.
description
doi_str_mv 10.3389/fpsyt.2020.549272
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a437638cb2854e84af2e3fdfbd3be546</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_a437638cb2854e84af2e3fdfbd3be546</doaj_id><sourcerecordid>2451860883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-4128c081934a8b91e5099f63b7a02bb0531236c20847046e4b62de115ee176c23</originalsourceid><addsrcrecordid>eNpVkUFP3DAQha2qVUGUH8Atx152sT22Y1-qUtRSJESlCs6W7Yx3g7J2aieo_PtmWVTBXGb03tM3h0fIGaNrAG3O41ifpjWnnK6lMLzl78gxU0qsqBL0_av7iJzW-kCXAWNAyY_kCIAqZpg8Jl9_Y8ip9h2WPm2aaYvNfcU4DwlrbXJsLrpub9y6If_NCZspN9_msWDKZdz2CT-RD9ENFU9f9gm5__H97vLn6ubX1fXlxc0qCMGnlWBcB6qZAeG0NwwlNSYq8K2j3HsqgXFQgVMtWioUCq94h4xJRNYuOpyQ6wO3y-7BjqXfufJks-vts5DLxroy9WFA6wS0CnTwXEuBWrjIEWIXfQcepVAL68uBNc5-h13ANBU3vIG-dVK_tZv8aFvJWgN6AXx-AZT8Z8Y62V1fAw6DS5jnarmQTCuqNSxRdoiGkmstGP-_YdTui7TPRdp9kfZQJPwDg6OQJg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2451860883</pqid></control><display><type>article</type><title>Reconsidering the Usefulness of Adding Naloxone to Buprenorphine</title><source>Open Access: PubMed Central</source><creator>Blazes, Christopher K. ; Morrow, Jonathan D.</creator><creatorcontrib>Blazes, Christopher K. ; Morrow, Jonathan D.</creatorcontrib><identifier>ISSN: 1664-0640</identifier><identifier>EISSN: 1664-0640</identifier><identifier>DOI: 10.3389/fpsyt.2020.549272</identifier><identifier>PMID: 33061915</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>addiction ; agonist therapy ; diversion ; opioids ; overdose ; Psychiatry ; substance use disorders</subject><ispartof>Frontiers in psychiatry, 2020-09, Vol.11, p.549272-549272</ispartof><rights>Copyright © 2020 Blazes and Morrow 2020 Blazes and Morrow</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-4128c081934a8b91e5099f63b7a02bb0531236c20847046e4b62de115ee176c23</citedby><cites>FETCH-LOGICAL-c442t-4128c081934a8b91e5099f63b7a02bb0531236c20847046e4b62de115ee176c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517938/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517938/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Blazes, Christopher K.</creatorcontrib><creatorcontrib>Morrow, Jonathan D.</creatorcontrib><title>Reconsidering the Usefulness of Adding Naloxone to Buprenorphine</title><title>Frontiers in psychiatry</title><subject>addiction</subject><subject>agonist therapy</subject><subject>diversion</subject><subject>opioids</subject><subject>overdose</subject><subject>Psychiatry</subject><subject>substance use disorders</subject><issn>1664-0640</issn><issn>1664-0640</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUFP3DAQha2qVUGUH8Atx152sT22Y1-qUtRSJESlCs6W7Yx3g7J2aieo_PtmWVTBXGb03tM3h0fIGaNrAG3O41ifpjWnnK6lMLzl78gxU0qsqBL0_av7iJzW-kCXAWNAyY_kCIAqZpg8Jl9_Y8ip9h2WPm2aaYvNfcU4DwlrbXJsLrpub9y6If_NCZspN9_msWDKZdz2CT-RD9ENFU9f9gm5__H97vLn6ubX1fXlxc0qCMGnlWBcB6qZAeG0NwwlNSYq8K2j3HsqgXFQgVMtWioUCq94h4xJRNYuOpyQ6wO3y-7BjqXfufJks-vts5DLxroy9WFA6wS0CnTwXEuBWrjIEWIXfQcepVAL68uBNc5-h13ANBU3vIG-dVK_tZv8aFvJWgN6AXx-AZT8Z8Y62V1fAw6DS5jnarmQTCuqNSxRdoiGkmstGP-_YdTui7TPRdp9kfZQJPwDg6OQJg</recordid><startdate>20200911</startdate><enddate>20200911</enddate><creator>Blazes, Christopher K.</creator><creator>Morrow, Jonathan D.</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200911</creationdate><title>Reconsidering the Usefulness of Adding Naloxone to Buprenorphine</title><author>Blazes, Christopher K. ; Morrow, Jonathan D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-4128c081934a8b91e5099f63b7a02bb0531236c20847046e4b62de115ee176c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>addiction</topic><topic>agonist therapy</topic><topic>diversion</topic><topic>opioids</topic><topic>overdose</topic><topic>Psychiatry</topic><topic>substance use disorders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blazes, Christopher K.</creatorcontrib><creatorcontrib>Morrow, Jonathan D.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blazes, Christopher K.</au><au>Morrow, Jonathan D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reconsidering the Usefulness of Adding Naloxone to Buprenorphine</atitle><jtitle>Frontiers in psychiatry</jtitle><date>2020-09-11</date><risdate>2020</risdate><volume>11</volume><spage>549272</spage><epage>549272</epage><pages>549272-549272</pages><issn>1664-0640</issn><eissn>1664-0640</eissn><pub>Frontiers Media S.A</pub><pmid>33061915</pmid><doi>10.3389/fpsyt.2020.549272</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-0640
ispartof Frontiers in psychiatry, 2020-09, Vol.11, p.549272-549272
issn 1664-0640
1664-0640
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a437638cb2854e84af2e3fdfbd3be546
source Open Access: PubMed Central
subjects addiction
agonist therapy
diversion
opioids
overdose
Psychiatry
substance use disorders
title Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T21%3A20%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reconsidering%20the%20Usefulness%20of%20Adding%20Naloxone%20to%20Buprenorphine&rft.jtitle=Frontiers%20in%20psychiatry&rft.au=Blazes,%20Christopher%20K.&rft.date=2020-09-11&rft.volume=11&rft.spage=549272&rft.epage=549272&rft.pages=549272-549272&rft.issn=1664-0640&rft.eissn=1664-0640&rft_id=info:doi/10.3389/fpsyt.2020.549272&rft_dat=%3Cproquest_doaj_%3E2451860883%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-4128c081934a8b91e5099f63b7a02bb0531236c20847046e4b62de115ee176c23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2451860883&rft_id=info:pmid/33061915&rfr_iscdi=true